(Q46650531)

English

Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography?

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

1 reference

based on heuristic

inferred from title

cholangiopancreatography

1 reference

based on heuristic

inferred from title

author name string

Brian R Weston

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

William A Ross

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Robert A Wolff

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Douglas Evans

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Jeffrey E Lee

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Xuemei Wang

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Lian-chun Xiao

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

Jeffrey H Lee

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

language of work or name

0 references

publication date

1 June 2008

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

112

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

2417-2423

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of anticancer agents in patients with impaired liver function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous biliary metal wall stenting in malignant obstructive jaundice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting early mortality following percutaneous stent insertion for malignant biliary obstruction: a multivariate risk factor analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom relief and quality of life after stenting for malignant bile duct obstruction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

AGA technical review on the evaluation of liver chemistry tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical approach to the patient with abnormal liver test results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery patterns of liver function after complete and partial surgical biliary decompression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23454

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23454

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18404695

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46650531&oldid=1424775261"